ScholarIQanswers from OpenAlex

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation

PaperCitations, authors & open-access status

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation have?

ScholarIQcitation count

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation has 34 citations in the OpenAlex counts ScholarIQ stores.

When was Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation published?

ScholarIQyear

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation has 2016 year in the ScholarIQ index.

What is the open-access status of Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation?

ScholarIQoa status

Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation has hybrid oa status in the ScholarIQ index.

What is the DOI of Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation?

ScholarIQdoi

The DOI for Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation is on the source record.

What is the PMID of Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation?

ScholarIQpmid

The PMID for Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation is on the source record.

What is the OpenAlex record for Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation?

ScholarIQopenalex

The OpenAlex for Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial